Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Can preformed fibril injections influence the features of PD?

Jeffrey Kordower, PhD from Rush University Medical Center, Chicago, IL, speaks with us about a recent study examining how injecting preformed fibrils of the protein alpha-synuclein, the misfolding of which is associated with the development of Parkinson’s disease (PD), could influence dopamine levels in an animal model. Dopamine is the neurotransmitter chiefly responsible for the main features of PD. Dr Kordower also talks about ongoing studies which are attempting to create animal models of Alzheimer’s Disease. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.